Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REVIVA PHARMACEUTICALS HOLDINGS, INC.

(RVPH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
3.6(c) 3.63(c) 3.63(c) 3.51(c) 3.56 Last
99 556 99 675 115 146 44 833 57 829 Volume
-4.76% +0.83% 0.00% -3.31% +1.42% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -9,82 M - -
Net Debt 2021 - - -
P/E ratio 2021 -5,32x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -18,8 M - -
Net Debt 2022 - - -
P/E ratio 2022 -4,08x
Yield 2022 -
Capitalization 49,1 M 49,1 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 5
Free-Float 61,5%
More Financials
Company
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops and seeks to commercialize therapeutics for various diseases. Its pipeline focuses on the central nervous system, respiratory, and metabolic diseases. It uses a chemical genomics driven technology platform and chemistry to develop new medicines. Its pipeline has two drug candidates, RP5063... 
Sector
Biotechnology & Medical Research
Calendar
12/08
More about the company
All news about REVIVA PHARMACEUTICALS HOLDINGS, INC.
11/26Certain Stock Options of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up..
CI
11/26Certain Warrants of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agre..
CI
11/26Certain Common Stock of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up ..
CI
11/15REVIVA PHARMACEUTICALS : Reports Third Quarter 2021 Financial Results and Recent Business ..
PU
11/15REVIVA PHARMACEUTICALS HOLDINGS, INC : Results of Operations and Financial Condition, Regu..
AQ
11/15Reviva Pharmaceuticals Holdings, Inc. Reports Third Quarter 2021áFinancial Results and ..
AQ
11/15REVIVA PHARMACEUTICALS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIA..
AQ
11/15Reviva Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Third Quarter an..
CI
09/20REVIVA PHARMACEUTICALS : Shareholder Director Nominations (Form 8-K)
PU
09/20REVIVA PHARMACEUTICALS HOLDINGS, INC : Shareholder Director Nominations (form 8-K)
AQ
09/15Reviva Pharmaceuticals to Present at the UpcomingáBenzinga Healthcare Small Cap Confere..
GL
09/02REVIVA PHARMACEUTICALS : to Present at the H.C. Wainwright 23rd Annual Global Investment C..
AQ
08/16REVIVA PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Recent Business..
PU
08/16REVIVA PHARMACEUTICALS HOLDINGS, INC : Results of Operations and Financial Condition, Regu..
AQ
08/16REVIVA PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Recent Business..
AQ
More news
News in other languages on REVIVA PHARMACEUTICALS HOLDINGS, INC.

- No features available -

More news
Analyst Recommendations on REVIVA PHARMACEUTICALS HOLDINGS, INC.
More recommendations
Chart REVIVA PHARMACEUTICALS HOLDINGS, INC.
Duration : Period :
Reviva Pharmaceuticals Holdings, Inc. Technical Analysis Chart | RVPH | US76152G1004 | MarketScreener
Technical analysis trends REVIVA PHARMACEUTICALS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 3,51 $
Average target price 13,00 $
Spread / Average Target 270%
EPS Revisions
Managers and Directors
Laxminarayan Bhat President, Chief Executive Officer & Director
Narayan Prabhu Chief Financial Officer
Parag Phoolchand Saxena Chairman
Marcus Cantillon Chief Medical Officer
Richard A. Margolin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
REVIVA PHARMACEUTICALS HOLDINGS, INC.-58.49%49
MODERNA, INC.188.59%122 239
LONZA GROUP AG25.98%57 878
IQVIA HOLDINGS INC.46.64%50 192
SEAGEN INC.-9.40%29 014
CELLTRION, INC.-41.36%24 745